% | $
Quotes you view appear here for quick access.

Alnylam Pharmaceuticals, Inc. Message Board

fmartinreviews 2 posts  |  Last Activity: Jun 30, 2016 11:48 AM Member since: Dec 7, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Robin Smith

    by kyman65 Jun 23, 2016 8:58 AM
    fmartinreviews fmartinreviews Jun 30, 2016 11:48 AM Flag

    so why are they putting a vote to stockholders? robin smith has a great point that the stock has been run into the ground the past three years. other companies making zero money, and without the intellectual property of this company have been faring far better. i can see why some stockholders blame management. at a MINIMUM, this stock should be at least a buck -- not in the pennies.

    Sentiment: Hold

  • fmartinreviews fmartinreviews Jun 27, 2016 5:35 PM Flag

    perhaps. that looks good on paper. but there's a reason the stock plummeted.
    how does the science affect the other potential products with the strategic alliances? that's the big question. right now -- unless this clinical hold is the FDA being overly cautious -- it looks like the best best for stockholders is an acquisition by a partner that sees value in the other parts.
    another big question is whether the recent financing will be scuttled. anyone who can give any updates or insight, please do.

77.18+1.18(+1.55%)11:45 AMEDT